Last updated 2026-07-20
- Raised $167M Undisclosed Round, May 2024
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
NewVale Capital is a sector-specialist pharma services growth equity firm investing in proven, revenue-generating services and enabling technology businesses serving the life sciences ecosystem. The firm partners with companies in the window between commercial proof points and commercial scale, providing right-sized capital and focused support to help evolve businesses into durable industry leaders.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is NewVale Capital's primary investment focus?
- NewVale Capital is a growth/expansion firm.
- Which sector does NewVale Capital primarily invest in?
- NewVale Capital has shown a focus on the Health Tech & Life Sciences sector, with one investment in this area.
- Can you name a notable company in NewVale Capital's portfolio?
- Beaconcure, a B2B company founded in 2016 that provides automated clinical data validation for regulatory submissions, is a portfolio company of NewVale Capital.
- What was NewVale Capital's most recent investment activity?
- NewVale Capital participated in a B Round for Beaconcure in March 2023, which raised $17.9M.
- What is the typical investment stage for NewVale Capital?
- NewVale Capital has participated in B Round investments.
- What is NewVale Capital's investment range?
- NewVale Capital's investment range is between $14M and $14M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2022 |
|---|